secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001437749-24-027846
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monopar regains compliance with Nasdaq minimum bid price rule
-------------------------------------------------------------

- Received Nasdaq notice that closing bid price was $1.00+ for 10 consecutive trading sessions.
- Compliance regained under Nasdaq Listing Rule 5550(a)(2), avoiding delisting risk.
- Company remains listed on Nasdaq Capital Market under ticker MNPR.
- Press release dated August 27, 2024; no other material updates provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924027846/0001437749-24-027846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924027846/mnpr20240827_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-027846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer